Predictive power of PSA patterns during off-time treatment periods with intermittent androgen deprivation

MET variant as a prognostic marker in clear cell renal cell carcinoma

Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer

Dissecting the biology of the androgen receptor pathway

HER2 positive breast cancer treatment, past and future

Breast cancer psychosocial and survivorship issues: are we doing better?

Male breast cancer: Opportunities for increased research funding and clinical trial access

Hypoxic metabolism in breast cancer: how to overcome resistance to anti-angiogenic therapy

Adjuvant bisphosphonate therapy in breast cancer

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Long term use of aromatase inhibitors and compliance

PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant